Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 36

    1.

    Protein-energy malnutrition as a risk factor for visceral leishmaniasis: a review.

    Malafaia G.

    Parasite Immunol. 2009 Oct;31(10):587-96. Review.PMID: 19751470 [PubMed - indexed for MEDLINE]Related articles

    2.

    Developments in the treatment of visceral leishmaniasis.

    den Boer ML, Alvar J, Davidson RN, Ritmeijer K, Balasegaram M.

    Expert Opin Emerg Drugs. 2009 Sep;14(3):395-410. Review.PMID: 19708817 [PubMed - indexed for MEDLINE]Related articles

    3.

    Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia.

    Soto J, Rea J, Valderrama M, Toledo J, Valda L, Ardiles J, Berman J.

    Am J Trop Med Hyg. 2009 Sep;81(3):387-9.PMID: 19706901 [PubMed - indexed for MEDLINE]Related articles

    4.

    Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment.

    Sundar S, Agrawal N, Arora R, Agarwal D, Rai M, Chakravarty J.

    Clin Infect Dis. 2009 Sep 15;49(6):914-8.PMID: 19663597 [PubMed - indexed for MEDLINE]Related articles

    5.

    Immunobiology of leishmaniasis.

    Sharma U, Singh S.

    Indian J Exp Biol. 2009 Jun;47(6):412-23. Review.PMID: 19634705 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pentavalent antimonials: new perspectives for old drugs.

    Frézard F, Demicheli C, Ribeiro RR.

    Molecules. 2009 Jun 30;14(7):2317-36. Review.PMID: 19633606 [PubMed - indexed for MEDLINE]Related articles

    7.

    The role of host genetics in leishmaniasis.

    Sakthianandeswaren A, Foote SJ, Handman E.

    Trends Parasitol. 2009 Aug;25(8):383-91. Epub 2009 Jul 18. Review.PMID: 19617002 [PubMed - indexed for MEDLINE]Related articles

    8.

    Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature.

    De Leonardis F, Govoni M, Lo Monaco A, Trotta F.

    Clin Exp Rheumatol. 2009 May-Jun;27(3):503-6. Review.PMID: 19604446 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis.

    Firdous R, Yasinzai M, Ranja K.

    Int J Dermatol. 2009 Jul;48(7):758-62.PMID: 19570087 [PubMed - indexed for MEDLINE]Related articles

    10.

    The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis.

    Peters NC, Sacks DL.

    Cell Microbiol. 2009 Sep;11(9):1290-6. Epub 2009 Jun 22. Review.PMID: 19545276 [PubMed - indexed for MEDLINE]Related articles

    11.

    Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis.

    Noazin S, Khamesipour A, Moulton LH, Tanner M, Nasseri K, Modabber F, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Smith PG.

    Vaccine. 2009 Jul 30;27(35):4747-53. Epub 2009 Jun 18. Review.PMID: 19540273 [PubMed - indexed for MEDLINE]Related articles

    12.

    Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe.

    Xynos ID, Tektonidou MG, Pikazis D, Sipsas NV.

    Emerg Infect Dis. 2009 Jun;15(6):956-9. Review.PMID: 19523302 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Drought, smallpox, and emergence of Leishmania braziliensis in northeastern Brazil.

    Sousa AQ, Pearson R.

    Emerg Infect Dis. 2009 Jun;15(6):916-21. Review.PMID: 19523291 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    LeishCyc: a biochemical pathways database for Leishmania major.

    Doyle MA, MacRae JI, De Souza DP, Saunders EC, McConville MJ, Likić VA.

    BMC Syst Biol. 2009 Jun 5;3:57.PMID: 19497128 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children.

    Shahian M, Alborzi A.

    Med Sci Monit. 2009 Jun;15(6):CR290-3.PMID: 19478699 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Leishmaniases in Bolivia: comprehensive review and current status.

    García AL, Parrado R, Rojas E, Delgado R, Dujardin JC, Reithinger R.

    Am J Trop Med Hyg. 2009 May;80(5):704-11. Review.PMID: 19407110 [PubMed - indexed for MEDLINE]Related articles

    17.

    Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis.

    Sundar S, Singh A, Agarwal D, Rai M, Agrawal N, Chakravarty J.

    Am J Trop Med Hyg. 2009 May;80(5):700-3.PMID: 19407109 [PubMed - indexed for MEDLINE]Related articles

    18.

    Genetics and visceral leishmaniasis: of mice and man.

    Blackwell JM, Fakiola M, Ibrahim ME, Jamieson SE, Jeronimo SB, Miller EN, Mishra A, Mohamed HS, Peacock CS, Raju M, Sundar S, Wilson ME.

    Parasite Immunol. 2009 May;31(5):254-66. Review.PMID: 19388946 [PubMed - indexed for MEDLINE]Related articles

    19.

    Perpetuation of Leishmania: some novel insight into elegant developmental programs.

    Milon G.

    Vet Res. 2009 Mar-Apr;40(2):38. Epub 2009 Apr 21. Review.PMID: 19379663 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Interventions for American cutaneous and mucocutaneous leishmaniasis.

    González U, Pinart M, Rengifo-Pardo M, Macaya A, Alvar J, Tweed JA.

    Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004834. Review.PMID: 19370612 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...